Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 24/3/2017
SIETES contiene 91704 citas

 
 
 1 a 20 de 22 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Sondergaard KB, Weeke P, Wissenberg M, Olsen A-MS, Fosbol EL, Lippert FK, Torp-Pedersen C, Gislason GH, Folke F. Non-steroidal anti-inflammatory drug use is associated with increased risk of out-of-hospital cardiac arrest: a nationwide case–time–control study. Eur Heart J 2017;3:100-7. [Ref.ID 101478]
2.Tiene citas relacionadas Cita con resumen
Gislason GH, Torp-Pedersen C. NSAIDs and the failing heart. BMJ 2016;354:i5163. [Ref.ID 100755]
3. Cita con resumen
Jorgensen ME, Hlatky MA, Kober L, Sanders RD, Torp-Pedersen C, Gislason GH, Jensen PF, Andersson C. ß-blocker-associated risks in patients with uncomplicated hypertension undergoing noncardiac surgery. JAMA Intern Med 2015;175:1923-31. [Ref.ID 99749]
4. Cita con resumen
Staerk L, Lip GYH, Olesen JB, Fosbol EL, Pallisgaard JL, Bonde AN, Gundlund A, Lindhardt TB, Hansen ML, Torp-Pedersen C, Gislason GH. Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study. BMJ 2015;351:h5876. [Ref.ID 99694]
5. Cita con resumen
Olsen A-MS, Lindhardsen J, Gislason GH, McGettigan P, Hlatky MA, Fosbøl E, Køber L, Torp-Pedersen C, Lamberts M. Impact of proton pump inhibitor treatment on gastrointestinal bleeding associated with non-steroidal anti-inflammatory drug use among post-myocardial infarction patients taking antithrombotics: nationwide study. BMJ 2015;351:h5096. [Ref.ID 99631]
6.Tiene citas relacionadas Cita con resumen
Schjerning Olsen A-M, Gislason GH, McGettigan P, Fosbol E, Sorensen R, Hansen ML, Kober L, Torp-Pedersen C, Lamberts M. Association of NSAID use with risk of bleeding and cardiovascular events in patients receiving antithrombotic therapy after myocardial infarction. JAMA 2015;313:805-14. [Ref.ID 98802]
7. Cita con resumen
Weeke P, Jensen A, Folke F, Gislason GH, Fosbol EL, Wissenberg M, Lippert FK, Christensen EF, Nielsen SL, Holm E, Kanters JK, Poulsen HE, Kober L, Torp-Pedersen C. Antipsychotics and associated risk of out-of-hospital cardiac arrest. Clin Pharmacol Ther 2014;96:490-7. [Ref.ID 97924]
8.Tiene citas relacionadas
Andersson C, Gislason GH, Torp-Pedersen C. Treatment with clopidogrel after myocardial infarction - Reply. JAMA 2012;308:2457. [Ref.ID 94264]
9. Cita con resumen
Schjerning Olsen AM, Fosbol EL, Lindhardsen J, Folke F, Charlot M, Selmer C, Olesen JB, Lamberts M, Ruwald MH, Kober L, Hansen PR, Torp-Pedersen C, Gislason GH. Long-term cardiovascular risk of nonsteroidal anti-inflammatory drug use according to time passed after first-time myocardial infarction: a nationwide cohort study. Circulation 2012;126:1955-63. [Ref.ID 94216]
10.Tiene citas relacionadas Cita con resumen
Andersson C, Lyngbaek S, Nguyen CD, Gislason GH, Kober L, Torp-Pedersen C. Association of clopidogrel treatment with risk of mortality and cardiovascular events following myocardial infarction in patients with and whithout diabetes. JAMA 2012;308:882-9. [Ref.ID 93727]
11. Cita con resumen
Lamberts M, Olesen JB, Ruwald MH, Hansen CM, Karasoy D, Kristensen SL, Kober L, Torp-Pedersen C, Gislason GH, Hansen ML. Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study. Circulation 2012;126:1185-93. [Ref.ID 93049]
12. Cita con resumen
Charlot M, Nielsen LH, Lindhardsen J, Ahlehoff O, Olsen AMS, Hansen ML, Hansen PR, Madsen JK, Kober L, Gislason GH, Torp-Pedersen C. Clopidogrel discontinuation after myocardial infarction and risk of thrombosis: a nationwide cohort study. Eur Heart J 2012;33:1-8. [Ref.ID 92708]
13. Cita con resumen
Bretler D-M, Hansen PR, Sorensen R, Lindhardsen J, Ahlehoff O, Andersson C, Abildstrom SZ, Torp-Pedersen C, Gislason GH. Discontinuation of hormone replacement therapy after myocardial infarction and short term risk of adverse cardiovascular events: nationwide cohort study. BMJ 2012;344:17. [Ref.ID 92673]
14.Enlace a cita original Cita con resumen
Jimenez-Solem E, Traerup Andersen J, Petersen M, Broedbaek K, Jensen JK, Afzal S, Gislason GH, Torp-Pedersen C, Poulsen HE. Exposure to selective serotonin reuptake inhibitors and the risk of congenital malformations: a nationwide cohort study. BMJ Open 2012:18 de junio. [Ref.ID 92642]
15.Tiene citas relacionadas Cita con resumen
Charlot M, Grove EL, Hansen PR, Olesen JB, Ahlehoff O, Selmer C, Lindhardsen J, Madsen JK, Kober L, Torp-Pedersen C, Gislason GH. Proton pump inhibitor use and risk of adverse cardiovascular events in aspirin treated patients with first time myocardial infarction: nationwide propensity score matched study . BMJ 2011;342:d2690. [Ref.ID 90752]
16. Cita con resumen
Schjerning Olsen AM, Fosbol EL, Lindhardsen J, Folke F, Charlot M, Selmer C, Lamberts M, Olesen JB, Kober L, Hansen PR, Torp-Pedersen C, Gislason GH. Duration of treatment with nonsteroidal anti-inflammatory drugs and impact on risk of death and recurrent myocardial infarction in patients with prior myocardial infarction. A nationwide cohort study. Circulation 2011;123:2226-35. [Ref.ID 90488]
17.Tiene citas relacionadas
Olesen JB, Lip GYH, Hansen ML, Hansen PR, Tolstrup JS, Lindhardsen J, Selmer C, Ahlehoff O, Olsen AMS, Gislason GH, Torp-Pedersen C. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ 2011;342:320. [Ref.ID 90162]
18.Tiene citas relacionadas Cita con resumen
Sorensen R, Hansen ML, Abildstrom SZ, Hvelplund A, Andersson C, Jorgensen C, Madsen JK, Hansen PR, Kober L, Torp-Pedersen C, Gislason GH. Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data. Lancet 2009;374:1967-74. [Ref.ID 87306]
19. Cita con resumen
Gislason GH, Rasmussen JN, Abildstrom SZ, Schramm TK, Hansen ML, Fosbol EL, Sorensen R, Folke F, Buch P, Gadsboll N, Rasmussen S, Poulsen HE, Kober L, Madsen M, Torp-Pedersen C. Increased mortality and cardiovascular morbidity associated with use of nonsteroidal anti-inflammatory drugs in chronic heart failure. Arch Intern Med 2009;169:141-9. [Ref.ID 85119]
20.Enlace a cita original
Fosbol EL, Gislason GH, Jacobsen S, Abildstrom SZ, Sorensen R, Rasmussen JN, Kober L, Madsen M, Torp-Pedersen C. The pattern of use of non-steroidal anti-inflammatory drugs (NSAIDs) from 1997 to 2005: a nationwide study on 4.6 million people. Pharmacoepidemiol Drug Saf 2008;17:822-33. [Ref.ID 83896]
Seleccionar todas
 
 1 a 20 de 22 siguiente >>